L. Jeremy Stigall Clear Point Neuro, Inc. (CLPT) insider trading activity

L. Jeremy Stigall is Chief Business Officer of ClearPoint Neuro, Inc.. Currently has a direct ownership of 74,308 shares of CLPT, which is worth approximately $889,466. The most recent transaction as insider was on Mar 12, 2025, when has been sold 5,545 shares (Common Stock) at a price of $13.18 per share, resulting in proceeds of $73,083. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.3K

53.14% 3M change

55.8% 12M change

Total Value Held $889,466

L. JEREMY STIGALL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2025	SELL Payment of exercise price or tax liability	$73,083 $13.18 p/Share	5,545 Reduced 6.94%	74,308 Common Stock
Mar 12 2025	BUY Exercise of conversion of derivative security	-	15,497 Added 16.25%	79,853 Common Stock
Mar 11 2025	SELL Payment of exercise price or tax liability	$37,680 $12.7 p/Share	2,967 Reduced 4.41%	64,356 Common Stock
Mar 11 2025	BUY Exercise of conversion of derivative security	-	8,292 Added 10.97%	67,323 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$83,901 $13.19 p/Share	6,361 Reduced 9.73%	59,031 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	-	17,777 Added 21.37%	65,392 Common Stock
Feb 22 2025	SELL Payment of exercise price or tax liability	$15,181 $16.72 p/Share	908 Reduced 1.87%	47,615 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	$1,137 $4.53 p/Share	251 Added 0.51%	48,523 Common Stock
Aug 20 2024	SELL Payment of exercise price or tax liability	$4,729 $11.26 p/Share	420 Reduced 0.86%	48,272 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$16,030 $4.58 p/Share	3,500 Added 6.71%	48,692 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$14,361 $5.74 p/Share	2,502 Reduced 5.25%	45,192 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$19,843 $6.24 p/Share	3,180 Reduced 6.25%	47,694 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	-	8,889 Added 14.87%	50,874 Common Stock
Feb 22 2024	SELL Payment of exercise price or tax liability	$7,782 $7.49 p/Share	1,039 Reduced 2.41%	41,985 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$2,181 $5.77 p/Share	378 Added 0.87%	43,024 Common Stock
Jul 06 2023	SELL Payment of exercise price or tax liability	$11,296 $6.53 p/Share	1,730 Reduced 3.9%	42,646 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$16,494 $6.15 p/Share	2,682 Added 5.7%	44,376 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$8,374 $6.91 p/Share	1,212 Reduced 2.82%	41,694 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$4,394 $8.55 p/Share	514 Reduced 1.18%	42,906 Common Stock
Aug 20 2022	SELL Payment of exercise price or tax liability	$2,688 $13.24 p/Share	203 Reduced 0.47%	42,692 Common Stock
Jul 06 2022	SELL Payment of exercise price or tax liability	$23,371 $13.87 p/Share	1,685 Reduced 3.9%	41,526 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	17,528 Added 28.86%	43,211 Common Stock

LJS

L. Jeremy Stigall

Chief Business Officer

Solana Beach, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLPT shares.

Notify only if

Value

Insider Trading

Get notified when an Clear Point Neuro, Inc. insider buys or sells CLPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ClearPoint Neuro, Inc.

Track Activities on CLPT

Account